Jatenzo 237 MG capsule 120S
Ended Awarded
- Contract number
- SPE2DB25FN3YD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,132
Award facts
- Contract value 100% obligated
- $1,131.87 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $1,131.87 delivery order to AmerisourceBergen Drug Corp for 120 capsules of Jantenzo 237 mg, a testosterone replacement therapy medication. This competitively awarded, firm fixed-price contract was executed on August 20, 2025, with an ultimate completion date of August 21, 2025. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, serves military and veteran healthcare systems through its comprehensive DLA framework agreement. The company maintains an extensive portfolio of pharmaceutical products spanning multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. As a leading prime contractor for the DLA Medical Supply Chain, AmerisourceBergen demonstrates significant capacity to fulfill federal healthcare requirements through open competition, supporting customers including the Defense Health Agency and U.S. Coast Guard across global military healthcare programs.
Quick answers
Who was awarded contract SPE2DB25FN3YD?
SPE2DB25FN3YD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 20, 2025.
How much is contract SPE2DB25FN3YD worth?
The government has obligated $1,132 on SPE2DB25FN3YD.
Is contract SPE2DB25FN3YD an order under another contract?
Yes. SPE2DB25FN3YD is a delivery order under SPE2DB22D1200, an indefinite delivery contract.
Was contract SPE2DB25FN3YD competed?
The extent of competition for SPE2DB25FN3YD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award